Chapter 77 – Erythrocyte Disorders in Infancy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Avery's Diseases of the Newborn

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-1-4377-0134-0.10077-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The α-thalassemias.

  2014cited by this paper
• Transient erythroblastopenia in infancy and childhood.

  2009cited by this paper
• Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple.

  2009cited by this paper
• Hematopoiesis: an evolving paradigm for stem cell biology.

  2008cited by this paper
• Fetal and neonatal haematological complications in monochorionic twins.

  2008cited by this paper
• Inherited Bone Marrow Failure Syndromes

  2007cited by this paper
• The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants.

  2006cited by this paper
• Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin.

  2006cited by this paper
• Delayed Cord Clamping in Very Preterm Infants Reduces the Incidence of Intraventricular Hemorrhage and Late-Onset Sepsis: A Randomized, Controlled Trial

  2006cited by this paper
• Crystalloid or colloid for partial exchange transfusion in neonatal polycythemia: A systematic review and meta‐analysis

  2005cited by this paper
• Randomized Trial of Liberal Versus Restrictive Guidelines for Red Blood Cell Transfusion in Preterm Infants

  2005cited by this paper
• Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease.

  2001cited by this paper
• The Diamond Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia.

  2001cited by this paper
• Reduction of Donor Exposures in Premature Infants by the Use of Designated Adenine–Saline Preserved Split Red Blood Cell Packs

  2001cited by this paper
• A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.

  2001cited by this paper
• Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome

  2001cited by this paper
• Twin-twin transfusion syndrome: etiology, severity and rational management

  2001cited by this paper
• Universal Newborn Screening for Hb H Disease in California

  2001cited by this paper
• Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates.

  2001cited by this paper
• The value of capillary whole blood lactate for blood transfusion requirements in anaemia of prematurity

  2001cited by this paper
• Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry

  2001cited by this paper
• Practice guidelines for prenatal and perinatal immunohematology, revisited

  2001cited by this paper
• Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis.

  2001cited by this paper
• International Forum

  2001cited by this paper
• Osteogenic Sarcoma Associated With Diamond–Blackfan Anemia: A Report From the Diamond–Blackfan Anemia Registry

  2001cited by this paper
• Meta‐analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity

  2001cited by this paper
• Erythropoietin Therapy for Premature Infants: Cost without Benefit?

  2000cited by this paper
• Changing outcome of homozygous alpha-thalassemia: cautious optimism.

  2000cited by this paper
• Sickle-cell disease not identified by newborn screening because of prior transfusion.

  2000cited by this paper
• Natural history of hereditary spherocytosis during the first year of life.

  2000cited by this paper
• Predischarge Bilirubin Screening in Glucose-6-Phosphate Dehydrogenase-Deficient Neonates

  2000cited by this paper
• Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.

  2000cited by this paper
• Twin-twin transfusion syndrome: a five year review

  2000cited by this paper
• Genetic and clinical features of hemoglobin H disease in Chinese patients.

  2000cited by this paper
• Feasibility and safety of AS-3 red blood cells for neonatal transfusions.

  2000cited by this paper
• Fumaric aciduria: Clinical and imaging features

  2000cited by this paper
• Clinical Manifestation of &bgr;-Thalassemia/Hemoglobin E Disease

  2000cited by this paper
• Detection of massive transplacental haemorrhage by flow cytometry.

  2000cited by this paper
• Methaemoglobinaemia secondary to topical lignocaine/ prilocaine in a circumcised neonate

  2000cited by this paper
• Fetal schistocytic hemolytic anemia and umbilical vein varix.

  2000cited by this paper
• Effect of recombinant human erythropoietin in preterm infants

  1999cited by this paper
• Neonatal Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Heterozygotes

  1999cited by this paper
• The estimation of fetomaternal haemorrhage

  1999cited by this paper
• Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study

  1998cited by this paper
• Treatment of hemoglobin Bart's hydrops with bone marrow transplantation.

  1998cited by this paper
• Hydrops Fetalis Caused by α-Thalassemia: An Emerging Health Care Problem

  1998cited by this paper
• Favism by proxy in nursing glucose-6-phosphate dehydrogenase-deficient neonates.

  1998cited by this paper
• Impact of transfusion guidelines on neonatal transfusions.

  1998cited by this paper
• Diamond-Blackfan anaemia: genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb

  1997cited by this paper
• Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision.

  1997cited by this paper
• Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia.

  1997cited by this paper
• Methylene blue-induced phototoxicity: an unrecognized complication.

  1996cited by this paper
• Hematologically important mutations: glucose-6-phosphate dehydrogenase.

  1996cited by this paper
• Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: Tabulation of mutant enzymes

  1996cited by this paper
• Clinical experience of management of thalassemia: the Sardinian experience.

  1996cited by this paper
• Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state

  1996cited by this paper
• Neonatal jaundice and molecular mutations in glucose‐6‐phosphate dehydrogenase deficient newborn infants

  1996cited by this paper
• Hematologic disorders in children from southeast Asia.

  1996cited by this paper
• Management of Late Anemia in Rhesus Hemolytic Disease: Use of Recombinant Human Erythropoietin (A Pilot Study)

  1996cited by this paper
• HEMOTOLOGICALLY IMPORTANT MUTATIONS : GLUSOSE-6-PHOSPHATE DEHYDROGENASE

  1996cited by this paper
• Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.

  1995cited by this paper
• Use of Erythropoietin in Premature Neonates: Controversies and the Future

  1995cited by this paper
• Methemoglobinemia Associated with Prilocaine Use in Neonatal Circumcision

  1995cited by this paper
• Literature Reviews: Neonatal-Perinatal Medicine: The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth Weight Infants Maier RF, Obladen N, Scigalla P, et al. N Engl J Med. 1994;330:1173-1178

  1995cited by this paper
• Hemoglobin F‐Cincinnati, α2Gγ2 41(C7) Phe → Ser in a newborn with cyanosis

  1995cited by this paper
• Developmental biology of hematopoiesis.

  1995cited by this paper
• Transient Erythroblastopenia of Childhood in Infants <6 Months of Age

  1994cited by this paper
• Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates.

  1994cited by this paper
• Effects of red cell transfusion on cardiac output and blood flow velocities in cerebral and gastrointestinal arteries in premature infants.

  1994cited by this paper
• Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity.

  1994cited by this paper
• Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.

  1994cited by this paper
• Erythropoietin and neonatal anemia.

  1994cited by this paper
• Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi.

  1994cited by this paper
• Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.

  1994cited by this paper
• Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.

  1994cited by this paper
• Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity.

  1994cited by this paper
• Skin microcirculation in neonatal polycythaemia and effects of haemodilution. Interaction between haematocrit, vasomotor activity and perfusion

  1993cited by this paper
• Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.

  1993cited by this paper
• Molecular genetic basis of the human Rhesus blood group system

  1993cited by this paper
• Effective use of a strategy using assigned red cell units to limit donor exposure for neonatal patients

  1993cited by this paper
• Prenatal determination of fetal RhD type by DNA amplification

  1993cited by this paper
• Erythropoietin therapy for anemia of prematurity.

  1993cited by this paper
• Clinical expression and laboratory detection of red blood cell membrane protein mutations.

  1993cited by this paper
• Double blind trial of recombinant human erythropoietin in preterm infants.

  1993cited by this paper
• Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis

  1993cited by this paper
• Dietary protein intolerance in infants with transient methemoglobinemia and diarrhea.

  1993cited by this paper
• Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.

  1993cited by this paper
• Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of prematurity.

  1993cited by this paper
• Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience.

  1992cited by this paper
• Case study. Erythropoietin for anaemia in a preterm Jehovah's Witness baby.

  1992cited by this paper
• Polycythemia of the preterm and full-term newborn infant: relationship between hematocrit and gestational age, total blood solutes, reticulocyte count, and blood pH.

  1992cited by this paper
• Effects of neonatal polycythemia and hemodilution on capillary perfusion.

  1992cited by this paper
• Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia.

  1992cited by this paper
• Reducing neonatal transfusions.

  1992cited by this paper
• Hyperbilirubinemia in Black Infants

  1992cited by this paper
• Hemolytic disease of the fetus: a plea for restraint.

  1992cited by this paper
• Neonatal polycythemia in appropriately grown infants of hypertensive mothers

  1992cited by this paper
• Transient erythroblastopenia in the first year of life

  1991cited by this paper
• Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.

  1991cited by this paper
• Transfusion therapy in neonates.

  1991cited by this paper

• Manifestations of HbSE sickle cell disease: a systematic review

  2021cites this paper
• Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia

  2020cites this paper
• Comparison of early surgical outcomes following anoplasty and limited PSARP for perineal fistula

  2020cites this paper
• ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program

  2018cites this paper
• Cord Hemoglobin in Newborns in Correlation with Maternal Hemoglobin in Northeastern Iran

  2015cites this paper
• Nadir Bir Olgu; Anti-jkb’ye Bağlı Yenidoğanın Hemolitik Hastalığı

  2015cites this paper
• Comparison of intra-procedural pain between a novel continuous arteriovenous exchange and conventional pull-push techniques of partial exchange transfusion in neonates: a randomized controlled trial

  2014cites this paper
• Perinatal factors in patent ductus arteriosus in very low‐birthweight infants

  2014cites this paper
• Risk Factors of Transfusion in Anemia of Very Low Birth Weight Infants

  2013cites this paper
• Isolated anaemia as a manifestation of Rh isoimmunisation

  2012cites this paper
• Hemodynamic alterations associated with polycythemia and partial exchange transfusion

  2011cites this paper
• Idiopathic Heinz body hemolytic anemia in an extremely low birth weight infant

  2010cites this paper
• Polycythemia of the newborn

  2010cites this paper
• Parents' compliance with specific medical instructions in newborn discharge letters.

  2010cites this paper